- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03364465
Lung Protective One-lung Ventilation With Fix and Variable Tidal Volume
Effect of Lung Protective One-lung Ventilation With Fix and Variable Tidal Volume on Oxygenation and Outcome: Randomized, Controlled Trial
During One-lung ventilation, the use of lower tidal volumes (VT) is helpful to avoid over-distension, provide sufficient oxygenation, but can result in increased atelectasis.
Nevertheless, it is not known if, during one-lung ventilation with constant low VT, moderate levels of PEEP combined with lung recruitment maneuvers are superior to variable low tidal volume for intraoperative oxygenation and protection against PPCs.
Aim of the study is to compare a strategy using constant tidal volume with recruitment maneuvers versus variable tidal volume with recruitment maneuvers during thoracic surgery in adults.
We hypothesize that in adult, non-obese patients undergoing thoracic surgery under standardized OLV with variable tidal volumes, modearte PEEP and recruitment maneuvers as compared to constant without recruitment maneuvers prevent PPCs.
Patients will be randomly assigned to one of two groups:
FIX TIDAL VOLUME GROUP (Groupfix): mechanical ventilation with constant (6 ml/kgIBW) tidal volume and PEEP of 5 cmH2O with recruitment maneuvers
VARIABLE TIDAL VOLUME GROUP (Groupvar): mechanical ventilation with variable (6 ml/kgIBW ± 33%) tidal volume with variable respiratory rate to maintain constant minute ventilation and PEEP of 5 cmH2O with recruitment maneuvers.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Lung separation will be performed by DLT technique. Mechanical ventilation will be applied in volume-controlled mode. During two-lung ventilation, VT will be set at 8 mL/kg predicted body weight. During one-lung ventilation, in GroupFix VT will be decreased to 6 mL/kg PBW with 5 cmH2O PEEP.
In GroupVar VT will be 6 ml/kg predicted body weight ±33% with 5 cmH2O PEEP. Respiratory rate will be adjusted to maintain same minute ventilation as during two-lung ventilation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Debrecen, Hungary, 4032
- University of Debrecen, Department of anesthesiology and Intensive Care
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient scheduled for open thoracic or video-assisted thoracoscopic surgery under general anesthesia requiring OLV (no emergency surgery)
- BMI < 35 kg/m2
- Age ≥ 18 years
- Expected duration of surgery > 60 min
- Expected duration of anesthesia > 90 min
Exclusion Criteria:
- COPD GOLD 3+4, lung fibrosis, documented bullae, severe emphysema, pneumothorax
- uncontrolled asthma
- NYHA 3+4, CCS 3+4
- previous thoracic surgery
- ARDS (Berlin definition)
- documented pulmonary arterial hypertension > 40 mmHg syst
- documented or suspected neuromuscular disease (thymoma, myasthenia)
- planned mechanical ventilation after surgery
- bilateral procedures
- lung separation with other method than DLT (eg diff. airway, tracheostomy)
- surgery in prone position
- persistent hemodynamic instability, intractable shock
- intracranial injury or tumor
- enrollment in other interventional study or refusal of informed consent
- pregnancy (excluded by anamnesis and/or laboratory analysis)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: GruopFix
one-lung ventilation with constant tidal volume
|
|
ACTIVE_COMPARATOR: GroupVariable
one-lung ventilation with variable tidal volume Intervention: change of ventilatory settings
|
change of tidal volume during one-lung ventilation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
intraoperative oxygenation
Time Frame: 1 day
|
PaO2 < 60 mmHg
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postoperative pulmonary complications
Time Frame: 90 days
|
infiltrate on chest X-ray, fever, laboratory and physical signs of infection
|
90 days
|
postoperative extra-pulmonary complications
Time Frame: 90 days
|
new atrial fibrillation
|
90 days
|
30-day survival/mortality
Time Frame: 30 days
|
number of death within 30 days after surgery
|
30 days
|
90-day survival/mortality
Time Frame: 90 days
|
number of death death within 90 days after surgery
|
90 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DE RKEB/IKEB 4737-2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Department of Health and Human ServicesNot yet recruitingHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
-
Methodist Health SystemCompletedHospital-acquired Pneumonia | Ventilator-associated PneumoniaUnited States
Clinical Trials on change of ventilatory settings
-
University of DebrecenCompletedEffect of Lung Protective One-lung Ventilation With Fix and Variable PEEP on Oxygenation and OutcomePneumonia | Hypoxemia | ARDS, Human | Pulmonary SepsisHungary
-
Instituto Canario de Investigacion BiomedicaAsociación Científica Pulmón y Ventilación MecánicaCompletedAcute Respiratory Distress Syndrome | Acute Lung Injury | Acute Respiratory FailureSpain
-
University of Turin, ItalyUnknownRespiratory Distress Syndrome, AdultItaly
-
Gonzalo Hernandez MartinezCompleted
-
University of California, Los AngelesNational Institutes of Health (NIH)CompletedEpilepsy | Sudden Cardiac DeathUnited States
-
Heinen und Löwenstein GmbH & Co. KGUnknownObstructive Sleep ApneaGermany
-
Seoul National University Bundang HospitalUnknownArterial Oxygenation During Protective One Lung VentilationKorea, Republic of
-
Jessa HospitalNot yet recruitingNeuropathy | Neurostimulator; Complication
-
University of AarhusAarhus University HospitalCompletedFluid Overload | HypovolemiaDenmark